BCART — Biocartis NV Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual income statement for Biocartis NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 27.8 | 37.4 | 43.1 | 48.3 | 57.5 |
| Cost of Revenue | |||||
| Gross Profit | 12.5 | 16.1 | 16.8 | 14.3 | 27.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 74.7 | 93 | 90 | 111 | 105 |
| Operating Profit | -46.9 | -55.6 | -46.9 | -62.6 | -47 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -48.3 | -64.2 | -63.2 | -71.7 | -65.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -48.2 | -64.1 | -62.9 | -71.5 | -65.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -48.2 | -64.1 | -62.9 | -71.5 | -65.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -48.2 | -64.1 | -62.9 | -71.5 | -65.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.821 | -0.997 | -0.97 | -1.08 | -1.08 |
| Dividends per Share |